Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs inHEART Models

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
inHEART Models
by inHEART

AI Verdict

Tool A focuses on real-time prediction and management of intraoperative hypotension using continuous hemodynamic monitoring. Tool B, conversely, specializes in creating detailed 3D digital twin models of the heart from imaging data to optimize pre-procedural planning for cardiac ablations. While both fall under Cardiology and Surgical AI, their distinct applications target different phases of patient care and clinical problems.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary concern is real-time, proactive management of hemodynamic stability to prevent hypotensive events. This tool is ideal for anesthesiologists and critical care teams needing early warnings and actionable insights into a patient's preload, afterload, and contractility during surgery or in the ICU. It helps clinicians intervene before hypotension occurs, potentially improving patient safety and outcomes.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose inHEART Models if…

Choose inHEART Models if you require advanced pre-procedural planning and visualization for complex cardiac ablation procedures. This AI-driven software is best suited for cardiologists and electrophysiologists performing image-guided ablations, offering highly detailed 3D digital twin models of the heart to optimize treatment strategies and potentially reduce procedure times and recurrence rates for conditions like ventricular tachycardia.

View inHEART Models →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform inHEART Models
Pricing Unknown Contact for pricing
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Cloud-based
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI is integrated into the Edwards Lifesciences HemoSphere platform, providing real-time, actionable insights with an intuitive HPI score and Smart Alerts for immediate proactive management during critical care. Its design focuses on continuous, integrated monitoring within a fast-paced environment, making it highly usable for acute patient management.

Clinical Value

inHEART Models

inHEART Models creates detailed 3D heart models for optimizing cardiac ablation procedures, with reported potential to reduce VT procedure times by 60% and recurrence rates by 38%. These specific, quantified improvements in efficiency and patient outcomes for complex interventions represent a highly impactful clinical advancement.

Pricing & Value

Tie

Both tools explicitly state 'contact-for-pricing' and do not publicly disclose their pricing details. This lack of transparency makes it impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A, Acumen HPI, is explicitly HIPAA compliant and integrated within the established Edwards Lifesciences HemoSphere platform, backed by a major medical device company with extensive existing hospital infrastructure and support. This provides a more straightforward path for enterprise adoption and ongoing support compared to Tool B, where HIPAA and BAA readiness are implied but not explicitly stated as 'yes' in the provided facts.

Innovation

inHEART Models

inHEART Models leverages AI to create highly detailed, interactive 3D 'digital twin' models of the heart from medical images for personalized pre-procedural planning and integration with EAM systems. This concept of a digital twin for complex anatomical procedures represents a more transformative and novel application of AI in precision medicine and surgical optimization.

Support & Docs

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A is offered by Edwards Lifesciences, a global leader in medical technology, which implies a robust and extensive global support infrastructure, comprehensive documentation, and established training programs. The provided information for Tool B, inHEART Models, does not include specific details on its support or documentation, making it reasonable to infer a stronger offering from the larger, more established vendor.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform inHEART Models
Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform inHEART Models
Company Edwards Lifesciences inHEART
Tagline Predicting and managing hypotension before it occurs. The world's most advanced, AI-enabled, DIGITAL TWIN OF THE HEART for image guided ablations.
Primary Function Uses machine learning to predict hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension. AI-driven software that creates detailed 3D digital twin models of the heart from CT/MR images, optimizing planning and execution of image-guided cardiac ablation procedures.
Key Feature: Prediction/Modeling Predicts hypotension up to 15 minutes in advance; HPI Parameter (0-100 likelihood score) AI-driven digital twin of the heart; Automated segmentation of CT and MR images
Key Feature: Insights/Monitoring Continuous hemodynamic monitoring; Relationship View screen (preload, afterload, contractility insights) Highly detailed, interactive 3D cardiac models; Pre-procedural planning and optimization of treatment strategies

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and inHEART Models.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI integrates into real-time hemodynamic monitoring during surgery or critical care, providing predictive insights directly on the Edwards Lifesciences HemoSphere platform. This means clinicians would primarily interact with the Edwards monitoring system. InHEART Models fits into the pre-procedural planning phase for cardiac ablations, generating 3D heart models that integrate with major electroanatomic mapping (EAM) systems. This would involve uploading imaging data and then utilizing the generated models within their existing EAM workflow.
Acumen HPI is integrated with the Edwards Lifesciences HemoSphere platform, and the provided information does not explicitly detail its direct EHR integration capabilities for data export or import. For inHEART Models, while it integrates seamlessly with major electroanatomic mapping systems, its direct EHR integration for image ingestion or report output would require further clarification with the vendor. Some hospitals have required lengthy risk assessments for inHEART's cloud-based image storage, which may impact EHR integration considerations.
Acumen HPI has demonstrated high accuracy in predicting hypotension, with studies showing a sensitivity of 90% and specificity of 89% at 10 minutes before an event, and a 57% reduction in the duration of intraoperative hypotension. InHEART Models has shown a potential to reduce VT procedure times by 60% and VT recurrence rates by 38%, indicating significant clinical impact on ablation outcomes.
For Acumen HPI, clinicians would need to learn to interpret the HPI score, smart alerts, and the relationship view on the Edwards monitoring platform, with setup videos and quick reference guides available. InHEART Models, while powerful for specialized procedures, may imply a steeper learning curve due to its complex 3D modeling and integration with specific EAM systems. Both companies would typically offer training and support to facilitate adoption and effective use.
For Acumen HPI, multi-site rollout would involve deploying the Edwards Lifesciences HemoSphere platform and dedicated sensors at each location, requiring hardware and infrastructure considerations. InHEART Models, being cloud-based, would focus on integrating with local CT/MR imaging systems and existing electroanatomic mapping systems across different sites, potentially simplifying hardware deployment but requiring robust network and data transfer protocols.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or inHEART Models

AI Tool Finder
AI-powered search. Results may not be comprehensive.